Nanotechnology – Specified use of nanostructure – For medical – immunological – body treatment – or diagnosis
Reexamination Certificate
2011-04-05
2011-04-05
Ford, Allison M (Department: 1651)
Nanotechnology
Specified use of nanostructure
For medical, immunological, body treatment, or diagnosis
C977S773000, C977S902000, C977S904000
Reexamination Certificate
active
07919699
ABSTRACT:
A method of uncoupling mitochondria in a subject including administering nanotubes to the subject in a therapeutically effective amount, wherein the nanotubes are self-rectifying is provided. A method of decreasing reactive oxygen species and decreasing detrimental loading of Ca2+into mitochondria is provided, including administering a pharmaceutically effective amount of nanotubes into the subject. A method of reducing weight, treating cancer, reducing the effects of traumatic brain injury, or reducing the effects of ageing, in a subject including administering a pharmaceutically effective amount of nanotubes into the subject is also provided.
REFERENCES:
patent: 4673691 (1987-06-01), Bachynsky
patent: 5853975 (1998-12-01), Tartaglia
patent: 6001578 (1999-12-01), Lind et al.
patent: 6472378 (2002-10-01), Von Borstel
patent: 6495680 (2002-12-01), Gong
patent: 6613875 (2003-09-01), Ghadiri
patent: 6685730 (2004-02-01), West et al.
patent: 2004/0023372 (2004-02-01), Klein et al.
patent: 2004/0038251 (2004-02-01), Smalley et al.
patent: 2004/0076681 (2004-04-01), Dennis et al.
patent: 2005/0096509 (2005-05-01), Olson
patent: WO 2004/089819 (2004-10-01), None
patent: WO 2006/043966 (2006-04-01), None
Clark, TD et al. Self-assembling cyclic beta3-peptide nanotubes as artificial transmembrane ion channels. J. Am. Chem. Soc. 1998. 120: 651-656.
Menon, VP et al. Fabrication and evaluation of nanoelectrode ensembles. Anal. Chem. 1995. 67: 1920-1928.
Martin, CR. Nanomaterials: A membrane-based synthetic approach. Science. 1994. 266: 1961-1966.
Martin, CR et al. Investigation of the transport properties of gold nanotubule membranes. J. Phys. Chem. B. 2001. 105: 1925-1934.
Supplementary European Search Report dated Mar. 20, 2009 (Four (4) pages).
Martin et al., “The Emerging Field of Nanotube Biotechnology,” Nature Reviews Drug Discovery, vol. 2, Jan. 2003, pp. 29-37.
Martin et al., “Materials Science: Expanding the Molecular Electronics Toolbox,” Science, Jul. 1, 2005, vol. 309, No. 5731, pp. 67-68.
Kohli et al., “Smart Nanotubes for Biotechnology,” Current Pharmaceutical Biotechnology, Feb. 2005, vol. 6, No. 1, pp. 35-47.
Nishizawa et al., “Metal Nanotubule Membranes with Electrochemically Switchable Ion-Transport Selectivity,” Science (1995), vol. 268, pp. 700-702.
Miller et al., “Electroosmotic Flow in Template-Prepared Carbon Nanotub Membranes,” J. Am. Chem. Soc. (2001), vol. 123, pp. 12335-12342.
Harper et al., “Mitochondrial uncoupling as a target for drug development for the treatment of obesity,” Obesity Reviews, vol. 2, No. 4, 255-265, 2001.
Kurt et al., “Dinitrophenol in weight loss: the poison center and public health safety,” Vet Hum Toxicol, (1986), vol. 28, pp. 574-575.
Tainter et al., “Dinitrophenol in the treatment of obesity: final report,” J. Am. Med. Assoc., vol. 105, pp. 332-337, 1935.
Sullivan et al., “Mitochondrial Uncoupling as a Therapeutic Target Following Neuronal Injury,” Journal of Bioenergetics and Biomembranes, Aug. 2004, vol. 36, No. 4, pp. 353-356.
Mattiasson et al., “The Emerging Functions of UCP2 in Health, Disease and Therapeutics,” Antioxidants & Redox Signaling, 2006, vol. 8, Nos. 1&2, pp. 1-38.
Hall et al.,Preserving Function in Acute Nervous System Injury. In: From Neuroscience to Neurology: Neuroscience, Molecular Medicine, and the Therapeutic Translation of Neurology, (S. Waxman, Ed.),Elsevier.Academic Press, Amsterdam, pp. 35-59, 2004.
Lipshitz et al., “Mitochondrial Damage and Dysfunction in Traumatic Brain Injury,” Mitochondrion, (2005), vol. 4, pp. 705-713.
Singh, “Time Course of Post-Traumataic Mitochondrial Oxidative Damage and Dysfunction in a Mouse Model of Focal Traumatic Brain Injury: Implications for Neuroprotective Therapy,” Journal of Cerebral Blood Flow & Metalbolism, In Press, Epub Mar. 15, 2006.
Gao et al., “In vivocancer targeting and imaging with semiconductor quantum dots,” Nature Biotechnology, Aug. 2004, vol. 22. No. 8, pp. 969-976.
Han et al., “Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules,” Nature Biotechnology, (2001), vol. 19, pp. 631-635.
Savic et al., “Micellar Nanocotainers distribute to defined cytoplamsic organelles,” Science, (2003), vol. 300, pp. 615-618.
Sullivan et al., “Mitochondrial Uncoupling Protein-2 Protects the Immature Brain from Excitotoxic Neuronal Death,” Annals of Neurology, (Jun. 2003) ,vol. 53, No. 6, pp. 711-717.
Sullivan et al., “The Ketogenic Diet Enhances Increases Mitochondrial Uncoupling Protein Levels and Activity In Mouse Hippocampus,” Annals of Neurology, (2004), vol. 55, pp. 576-580.
Brown et al., “Brain region-specific, age-related, alterations in mitochondrial responses to elevated calcium,” Journal of Bioenergetics and Biomembranes, (2004), vol. 36, pp. 401-406.
Jin et al., “The Mitochondrial Uncoupling Agent 2,4-Dinitrophenol Improves Mitochondrial Function, Attenuates Oxidative Damage, and Increases White Matter Sparing in the Contused Spinal Cord,” Journal of Neurotrauma, (2004), vol. 21, pp. 1396-1404.
Korde et al., “The uncoupling agent 2,4-dinitrophenol improves mitochondrial homeostasis following striatal quinolinic acid injections,” Journal of Neurotrauma, (2005), vol. 22, pp. 1142-1149.
Lin et al., “The gene gun: current applications in cutaneous gene therapy,” (2000) Int. J. Dermatol., vol. 39, No. 3, pp. 161-170.
Korde, “The Mitochondrial uncoupler 2, 4-dinitrophenol attenuates tissue damage and improves mitochandrial homeostasis following transient focal cerebral ischemia”, J Neurochem, (2005), vol. 94, No. 6, pp. 1676-1684.
Remington's Pharmaceutical Sciences, Mace Publishing Company, Philadelphia, Pennyslvania, 17th Ed (1985).
Charles Martin et al., The Emerging Field of Nanotube Biotechnology, Nature Reviews Drug Discovery, vol. 2, Jan. 2003, pp. 29-37.
Crowell & Moring LLP
Fernandez Susan E
Ford Allison M
University of Kentucky Research Foundation
LandOfFree
Nanotubes as mitochondrial uncouplers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanotubes as mitochondrial uncouplers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanotubes as mitochondrial uncouplers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2730470